X0306
4
2021-12-21
0
0001588972
Recro Pharma, Inc.
REPH
0001535264
AWM Investment Company, Inc.
527 MADISON AVENUE
SUITE 2600
NEW YORK
NY
10022
0
0
1
0
Common Stock
2021-12-21
4
S
0
99398
1.5517
D
5081901
I
By Limited Partnerships
This is a weighted average price.
AWM Investment Company, Inc., a Delaware Corporation (AWM), is the investment adviser to Special Situations Fund III QP, L.P. (QP), Special Situations Cayman Fund, L.P. (Cay) and Special Situations Private Equity Fund, L.P. (PE). (PE together with QP and Cay the Funds). As the investment adviser to the Funds, AWM holds sole voting and investment power over 3,153,693 shares of Common Stock of the Issuer (the Shares) held by QP, 1,103,377 Shares held by Cay and 824,831 Shares held by PE.
Austin W. Marxe (Marxe), David M. Greenhouse (Greenhouse) and Adam C. Stettner (Stettner) are the controlling principals of AWM.
The reporting person disclaims beneficial ownership of the Shares, except to the extent of its pecuniary interest therein. This report shall not
be deemed an admission that the reporting person is the beneficial owner of the securities reported herein for purposes of Section 16 of the
Securities Exchange Act of 1934, as amended, or for any other purpose.
Adam Stettner
2021-12-23